Dr. Charles P. Venditti, a clinical and biochemical geneticist, is a Senior Investigator and Chief of the Metabolic Medicine Branch in the National Human Genome Research Institute at the National Institutes of Health in Bethesda, MD. With an outstanding group of clinical and laboratory colleagues, he has developed a translational research program to study the natural history and clinical phenotype(s) of the hereditary methylmalonic acidemias (MMA), cobalamin metabolic disorders, and propionic acidemia (PA). His laboratory is developing gene, cell and small molecules therapeutics to treat MMA and PA.
Dr Venditti has received numerous awards, including a Presidential Early Career Award for Scientists and Engineers (PECASE), the US Government's highest honor for early-career scientists. He is an elected member of the American Society of Clinical Investigation (ASCI), serves on numerous medical, advisory and editorial boards, and is a frequent ad hoc reviewer for local, national, and international granting agencies. He has authored more than 235 peer reviewed research articles, reviews, textbook chapters, invention reports, and patent applications.